Tong Ren Tang Technologies Co. Ltd. provided earnings guidance for the twelve months ended 31 December 2023. For the period the Group is expected to range from a decrease by approximately 3% to an increase by approximately 7% as compared to the corresponding period of last year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 HKD | +7.71% | +12.74% | -18.93% |
Mar. 22 | Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | China Permits Clinical Trial of Tong Ren Teng's Anti-Blood Stasis Drug | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.93% | 869M | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- 1666 Stock
- News Tong Ren Tang Technologies Co. Ltd.
- Tong Ren Tang Technologies Co. Ltd. Provides Earnings Guidance for the Twelve Months Ended 31 December 2023